Source: International Congress 2017 – Translational studies of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Houssaini (München, Germany). mTOR Pathway Activation Drives Lung-Cell Senescence and Emphysema in Chronic Obstructive Pulmonary Disease. 3921

Member's Comments

No comment yet.

Related content which might interest you: Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 2014 Year: 2014 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 1999 Year: 1999 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 From the Cradle to the Grave - The Early-Life Origins of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Chronic Obstructive Pulmonary Disease: A Forgotten Killer Source: Eur Respir J 2009; 33: 456 Year: 2009 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Increased Exacerbations of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Carriers Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Patterns of Oxygen Pulse Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020